The report will be delivered in 2-3 business days.

Anti-Hypertensive Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7036 | Format :


The anti-hypertensive drugs market consists of sales of anti-hypertensive drugs and related services. These drugs are re used to prevent heart failure, kidney failure and acute stroke induced by hypertension. Some of the major anti-hypertensive drugs include Diuretics, Angiotensin-converting enzyme (ACE) inhibitors, and Angiotensin II receptor antagonists.

The global anti-hypertensive drugs market was valued at about $13.8 billion in 2018 and is expected to decline to $9.72 billion at a CAGR of -8.4% through 2022.

North America was the largest region in the anti-hypertensive drugs market. This region is expected to remain the largest during the next five years. The anti-hypertensive drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Sedentary lifestyle is a major driver for the growth of the anti-hypertensive drugs market. Consumption of junk food, lack of proper healthy and balanced diet, lack of proper sleep due to irregular workshifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed of hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.

Low awareness of the antihypertensive drugs amongst the population is one of the major restraints in the Anti-Hypertensive Drugs market. Firstly, most of the people in developing nations neglect their health-checkups and are not aware about the existing hypertension condition in them until they detect extreme symptoms Secondly, persons diagnosed with hypertension are not adherent to their medication schedule and stop taking medication after 1-2 weeks until symptoms return, thereby posing a huge challenge to the anti-hypertensive drugs market. For example, in the year 2016, BMC Research notes published a research survey (from a developing country) which states that out of the total 112 hypertensive subjects with stroke, only 17% of them were adherent to antihypertensive medications. Lack of awareness and low drug adherence restraint the growth of antihypertensive market.

Of late, there has been rise in use of combination therapies compared to monotherapy treatment. Monotherapy is the treatment of a hypertension with a single drug, while the use of combinations of drugs (Combination Therapy) allows for action on several different hypertensive mechanisms. When we combine the two drugs with different mechanisms of action, the effect is two to five times greater than monotherapy. Increasing the dose of monotherapy reduces coronary events by 29% and cerebrovascular events by 40%, while combining two antihypertensive agents with a different mechanism of action reduces coronary events by 40% and cerebrovascular events by 54%. Thus, the use of combination therapy provides greater protection to a target organ than increasing the dose of monotherapy. The trend of using combination therapy is thus more effective and is being widely accepted as well.

The US Food and Drug Administration (FDA) issued a guidance on developing fixed-combination drugs to treat hypertension. This primarily focuses on the clinical development of two-drug combinations of previously approved products. US FDA expects to see a reduction in adverse effects for combinations that include doses below each drugs’ maximum dose compared to single drug regimens at their maximum dose. Earlier physicians typically started a patient on a single drug and titrated up to a maximum dose before adding additional drugs to their programme, current guidelines recommend starting patients on two drugs at less than their full doses. Hence, this guidance would keep a check on the fixed-combination drugs.

Major players in the market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd. and Pfizer, Inc.

    1. Executive Summary

    2. Anti-Hypertensive Drugs Market Characteristics

    3. Anti-Hypertensive Drugs Market Size And Growth

    3.1. Global Anti-Hypertensive Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Anti-Hypertensive Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Anti-Hypertensive Drugs Market Segmentation

    4.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Diuretics  

    Angiotensin Receptor Blockers (ARBs)  

    Angiotensin Converting Enzyme (ACE) Inhibitors  

    Beta Blockers

    Alpha Blockers

    Calcium Channel Blockers  

    Renin Inhibitors

    Vasodilators  

    4.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Primary Hypertension

    Secondary Hypertension

    4.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals  

    Clinics

    Homecare  

    5. Anti-Hypertensive Drugs Market Regional And Country Analysis

    5.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Anti-Hypertensive Drugs Market  

    6.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview  

    6.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Anti-Hypertensive Drugs Market  

    7.1. China Anti-Hypertensive Drugs Market Overview  

    7.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Anti-Hypertensive Drugs Market  

    8.1. India Anti-Hypertensive Drugs Market Overview  

    8.2. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Anti-Hypertensive Drugs Market  

    9.1. Japan Anti-Hypertensive Drugs Market Overview  

    9.2. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Anti-Hypertensive Drugs Market  

    10.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Anti-Hypertensive Drugs Market  

    11.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Anti-Hypertensive Drugs Market  

    12.1. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Anti-Hypertensive Drugs Market  

    13.1. Western Europe Anti-Hypertensive Drugs Market Overview

    13.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Anti-Hypertensive Drugs Market  

    14.1. UK Anti-Hypertensive Drugs Market Overview

    14.2. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Anti-Hypertensive Drugs Market  

    15.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Anti-Hypertensive Drugs Market  

    16.4. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Anti-Hypertensive Drugs Market  

    17.1. Eastern Europe Anti-Hypertensive Drugs Market Overview

    17.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Anti-Hypertensive Drugs Market  

    18.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Anti-Hypertensive Drugs Market  

    19.1. North America Anti-Hypertensive Drugs Market Overview

    19.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Anti-Hypertensive Drugs Market  

    20.1. USA Anti-Hypertensive Drugs Market Overview

    20.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Anti-Hypertensive Drugs Market  

    21.1. South America Anti-Hypertensive Drugs Market Overview

    21.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Anti-Hypertensive Drugs Market  

    22.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Anti-Hypertensive Drugs Market  

    23.1. Middle East Anti-Hypertensive Drugs Market Overview

    23.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Anti-Hypertensive Drugs Market  

    24.1. Africa Anti-Hypertensive Drugs Market Overview

    24.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles

    25.1. Anti-Hypertensive Drugs Market Competitive Landscape

    25.2. Anti-Hypertensive Drugs Market Company Profiles

    25.2.1. Merck & Co. Inc.

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Astra Zeneca Plc

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Daiichi Sankyo Company Limited

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Johnson & Johnson Ltd.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Pfizer, Inc.

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market

    27. Anti-Hypertensive Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: India, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: UK, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: France, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: North America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: USA, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: South America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Merck & Co. Inc. Financial Performance
  • Table 47: Astra Zeneca Plc Financial Performance
  • Table 48: Daiichi Sankyo Company Limited Financial Performance
  • Table 49: Johnson & Johnson Ltd. Financial Performance
  • Table 50: Pfizer, Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: China, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: India, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: India, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: France, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: France, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Merck & Co. Inc. Financial Performance
  • Figure 47: Astra Zeneca Plc Financial Performance
  • Figure 48: Daiichi Sankyo Company Limited Financial Performance
  • Figure 49: Johnson & Johnson Ltd. Financial Performance
  • Figure 50: Pfizer, Inc. Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)